Related Experiment Video
Updated: Jul 4, 2026
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Molecular analysis of early host cell infection by Trypanosoma cruzi
Fernando Villalta1, M Nia Madison, Yuliya Y Kleshchenko
1Department of Microbial Pathogenesis and Immune Response, School of Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37208-3599, USA. fvillalta@mmc.edu
Insights
Chagas heart disease, caused by Trypanosoma cruzi, requires new treatments. Understanding early cellular infection by T. cruzi is key to developing novel inhibitors and therapies.
Area of Science:
- Parasitology
- Molecular Biology
- Cell Biology
Background:
- Chagas heart disease, caused by Trypanosoma cruzi, affects millions, with rising concerns in the US due to immigration.
- Current treatments for T. cruzi infection have severe side effects and are ineffective for chronic cases.
Purpose of the Study:
- To critically analyze the molecular and cellular mechanisms of early Trypanosoma cruzi infection.
- To identify potential targets for novel therapeutic interventions against T. cruzi.
Main Methods:
- Review of existing literature on T. cruzi cellular invasion.
- Analysis of molecular and structural data related to T. cruzi-host interactions.
Main Results:
- Early T. cruzi infection involves complex molecular and cellular processes.
- Candidate T. cruzi invasive genes and host factors are emerging as critical players.
- Trypanosome invasive proteins represent promising targets for drug development.
Conclusions:
- A deeper understanding of T. cruzi early infection is crucial for designing effective inhibitors.
- Advances in cell biology of T. cruzi infection can lead to novel cell-based therapies.
- Targeting T. cruzi invasive proteins offers a promising strategy for disease intervention.
Abstract:
Trypanosoma cruzi, the causative agent of Chagas heart disease, infects heart and other cells leading to cardiac arrest frequently followed by death. The disease affects millions of individuals in the Americas and is posing health problems because of blood transmission in the US due to large Latin American immigration. Since the current drugs present serious side effects and do not cure the chronic infection, it is critically important to understand the early process of cellular infection at the molecular and structural levels to design novel inhibitors to block T. cruzi infection. In this review, the authors critically analyze the molecular and cellular basis of early T. cruzi infection and discuss the future directions in this area. The candidate T. cruzi invasive genes and host genes involved in the process of early infection are just beginning to be understood. The trypanosome invasive proteins are excellent targets for intervention. The progress made in the cell biology of T. cruzi infection will also facilitate the development of novel cell-based therapies to ameliorate the disease.
